TIP vs SCHP: returns, risk and drawdowns compared
iShares TIPS Bond ETF against Schwab U.S. TIPS ETF, over the same 16 years (September 2010 to October 2026) with dividends reinvested.
Data updated October 2026
TIP
iShares TIPS Bond ETF
10,000 became
14,880
- A year on average
- +2.5%
- Annual volatility
- 5.1%
- Deepest fall
- −13.9%
- Worst month
- −6.7%
SCHP
Schwab U.S. TIPS ETF
10,000 became
12,802
- A year on average
- +1.5%
- Annual volatility
- 5.1%
- Deepest fall
- −17.0%
- Worst month
- −7.0%
TIP came out ahead by 0.9 percentage points a year from September 2010 to October 2026. SCHP swung more (5.1% against 5.1% a year). The correlation of monthly returns was 1.00: they moved almost in lockstep.
Growth of 10,000: TIP vs SCHP
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero TIP had returned more, below zero SCHP. TIP was ahead in 100% of the 159 three-year periods.
Annualised 3-year return of TIP minus that of SCHP, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: TIP −13.9%, SCHP −17.0%.
All the figures
| TIP | SCHP | |
|---|---|---|
| Annual return (CAGR) | +2.5% | +1.5% |
| Total return | +49% | +28% |
| Annual volatility | 5.1% | 5.1% |
| Deepest fall (month-end) | −13.9% | −17.0% |
| Worst month | −6.7% | −7.0% |
| Best month | +4.8% | +4.8% |
| Positive months | 61% | 60% |
| Best year | 2011: +13.3% | 2011: +11.8% |
| Worst year | 2022: −12.3% | 2022: −14.9% |
| 1-year return | −1.6% | −1.5% |
| 5 years, a year | −0.1% | −1.2% |
| 10 years, a year | +2.1% | +1.0% |
| Trading currency | USD | USD |
First nine rows: the same 194 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half TIP, half SCHP
| TIP alone | SCHP alone | 50/50 | |
|---|---|---|---|
| A year on average | +2.5% | +1.5% | +2.0% |
| Annual volatility | 5.1% | 5.1% | 5.1% |
| Deepest fall (month-end) | −13.9% | −17.0% | −15.2% |
| Worst month | −6.7% | −7.0% | −6.9% |
With a correlation of 1.00 the mix behaved almost like either fund alone: its volatility of 5.1% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, TIP or SCHP?
From September 2010 to October 2026, TIP returned +2.5% a year and SCHP +1.5% a year, with dividends reinvested. Over rolling 3-year periods TIP did better in 100% of cases. Past returns do not predict future returns.
Which is riskier, TIP or SCHP?
Over the same months annual volatility was 5.1% for TIP and 5.1% for SCHP; the deepest fall from a month-end high was 13.9% and 17.0%, and the worst single month −6.7% and −7.0%.
How correlated are TIP and SCHP?
The correlation of their monthly returns was 1.00: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both TIP and SCHP?
Half in each, rebalanced every month, returned +2.0% a year over the same period, with 5.1% annual volatility and a deepest month-end fall of 15.2%.
More comparisons
- TIP — iShares TIPS Bond ETFReturns, drawdowns and risk
- SCHP — Schwab U.S. TIPS ETFReturns, drawdowns and risk
- TIP vs VTIP
- TIP vs IBCI
- IEF vs TIP
- SCHP vs VTIP
- SCHP vs IBCI
- What a crisis would do to your portfolioYour own scenarios, holding by holding
- Portfolio stress testing software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.